Atlas Trials

Opus Genetics, Inc

3 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Opus Genetics, Inc

RecordFirmDate
Safety and Tolerability of Subretinal OPGx-RDH12-1001 for LCA-Associated Inherited Retinal Degeneration (LCA-IRD) (NCT07681778)Opus Genetics, Inc2026-09-01
Safety and Tolerability of Subretinally Injected OPGx-BEST1 in Patients With Best Vitelliform Macular Dystrophy (BVMD) or Autosomal-Recessive Bestrophinopathy (ARB) (NCT07185256)Opus Genetics, Inc2025-09-25
Safety and Tolerability Subretinal OPGx-001 for LCA5-Associated Inherited Retinal Degeneration (LCA5-IRD) and Non-interventional Arm With Untreated Patients (NCT05616793)Opus Genetics, Inc2023-06-15

Track Opus Genetics, Inc automatically

Every clearance here is in the API, with alerts when new ones post.